Please login to the form below
accessibility
This page shows the latest accessibility news and features for those working in and with pharma, biotech and healthcare.
Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
While congress works toward additional COVID-19 funding, Lilly and the US government will continue to work together to support the availability of bebtelovimab to maximise equity and accessibility in the
Latest news
-
Sandoz launches ‘Act4Biosimilars’ initiative to address global health inequalities
The initiative is focused on increasing patient access to advanced medicines by following ‘the 4 A’s of biosimilars’, which involve allowing for greater approvability, accessibility, acceptability and affordability.
-
Motor Neurone Disease Association and tech innovators collaborate to produce I Will Always Be Me
True accessibility is about recognising the human experience and building around it.”.
-
FDA authorises flexible storage for Pfizer/BioNTech COVID-19 vaccine
It gives people more storage options, and more accessibility in locations that today may not be ordering the Pfizer vaccine,” Tanya Alcorn, vice president of Pfizer’s BioPharma Global Supply Chain
-
Key emerging trends in digital health
From the ever-increasing availability of new apps aiming to help the management of chronic disease to the increasing popularity of video doctor appointments, digital technologies offer improved accessibility and ease
-
LifeArc creates £10m COVID-19 research fund
on the manufacture and accessibility of the drug.
More from news
Approximately 1 fully matching, plus 67 partially matching documents found.
Latest Intelligence
-
Delivering content to fuel omnichannel engagement
This enhances audience engagement and improves the impact of medical education through accessibility, convenience and relevance.
-
Expanding clinical trial access: a global imperative requiring local focus
Opportunities to participate in trials can be limited for certain demographic groups due to trial sites’ geographical locations and related accessibility as well as other cultural and socioeconomic variables.
-
Decentralised clinical trials: mapping patient pathways with a focus on patient-centricity
However, there are still some challenges that – if not properly addressed during trial design – can reduce trial and technology accessibility.
-
Home or away: where next for pharmaceutical symposia?
Also, by increasing event accessibility and convenience, you can catch a wider audience.
-
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
If you can increase that accessibility and convenience for them, then you can get a much wider audience than you would at a conference,” Burgoyne added.
More from intelligence
Approximately 0 fully matching, plus 37 partially matching documents found.
Latest appointments
-
Changes at Oxford PharmaGenesis, Synergy Vision and akt health communications
underpinned by relevant local knowledge and accessibility for clients around the world.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Promoting trust: Cuttsy+Cuttsy become a PIF Tick accredited agency
Tick. A PIF Tick quality mark is assigned to an organisation whose health information meets ten specific criteria points covering aspects such as design, usability, accessibility and user engagement.
-
The future of medical meetings: Leveraging the potential of hybrid events
However, while this change is welcomed, the past two years have seen huge innovation in virtual technology that has extended the global reach, accessibility and measurability of many medical educational events –
-
Removing Barriers to Pharmaceutical Accessibility & Affordability Worldwide
Dhiren Thakker, Founding President and CEO at Med Aditus, shares his insights into how blockchain and other leading-edge technologies can help revolutionize pharmaceutical manufacturing in sub-Saharan Africa and globally. He will also explore
-
Improving healthcare for rare disease patients
Following on from Rare Disease Day 2022, we decided to take a deeper look into the patient journey of those living with a rare health condition. In this blog, we discuss how their experiences may differ from those living with more prevalent
-
Advancing Our Profession: Driving Leadership and Best Practices in Medical Communications – Key themes and highlights from the 2022 European Meeting of ISMPP
Our analysis showed that although nearly 60% of journals had information in their guidelines on this topic, there was a general lack of consistency and accessibility (Hawkins et al.
More from PMHub
Approximately 1 fully matching, plus 26 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- A new era for UK-Japanese scientific research relations
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
- Realising the potential of omnichannel in medical communications
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- AI is transforming pharma R&D – now it can transform pharma marketing
- J&J’s Darzalex shows ‘significant’ survival benefit in newly diagnosed multiple myeloma
- Six UK universities receive grant for research into motor neurone disease
- My journey advancing the science in pulmonary hypertension
PMHub
Havas Life Medicom
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
